Epstein-barr virus but not cytomegalovirus is associated with reduced vaccine antibody responses in Gambian infants

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Holder, Beth ^a   Miles, David J C ^a,b   Kaye, Steve ^c   Crozier, Sarah ^a,d   Mohammed, Nuredin Ibrahim ^a,e   Duah, Nancy O ^a,e   Roberts, Elishia ^a   Ojuola, Olubukola ^a   Palmero, Melba S ^a   Touray, Ebrima S ^a   Waight, Pauline ^f   Cotten, Matthew ^a   Rowland Jones, Sarah ^a   van der Sande, Marianne ^g,h   Whittle, Hilton ^a  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f PUBLIC HEALTH ENGLAND   (United Kingdom)

^g NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; MEASLES VACCINE; MENINGOCOCCUS VACCINE; VIRUS ANTIBODY;

ANTIBODY RESPONSE; ARTICLE; CHILD; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG RESPONSE; EPSTEIN BARR VIRUS INFECTION; GAMBIA; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFANT; MAJOR CLINICAL STUDY; MEASLES; MENINGOCOCCOSIS; PREDICTION; PRESCHOOL CHILD; T LYMPHOCYTE; VACCINATION; ANTIBODY SPECIFICITY; BLOOD; CYTOMEGALOVIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; IMMUNOLOGY; METHODOLOGY; TIME;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 4; NEISSERIA MENINGITIDIS;

ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPSTEIN-BARR VIRUS INFECTIONS; GAMBIA; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; MEASLES VACCINE; MENINGOCOCCAL VACCINES; TIME FACTORS; VACCINATION;

EID: 78649528458     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014013     Document Type: Article

References (53)

1. Poliomyelitis Commission of the Western Region Ministry of Health N (1966) Poliomyelitis vaccination in Ibadan, Nigeria, during 1964 with oral vaccine (Sabin strains). Bull World Health Organ 34: 865-876.
2. Williamson W, Greenwood B (1978) Impairment of the immune response to vaccination after acute malaria. Lancet 1: 1328-1329.
3. Usen S, Milligan P, Ethevenaux C, Greenwood B, Mulholland K (2000) Effect of fever on the serum antibody response of Gambian children to Haemophilus influenzae type b conjugate vaccine. Pediatr Infect Dis J 19: 444-449.
4. Lynn T, Beller M, Funk E, Middaugh J, Ritter D, et al. (2004) Incremental effectiveness of 2 doses of measles-containing vaccine compared with 1 dose among high school students during an outbreak. J Infect Dis 189 Suppl 1: S86-90.
5. Janaszek W, Gay N, Gut W (2003) Measles vaccine efficacy during an epidemic in 1998 in the highly vaccinated population of Poland. Vaccine 21: 473-478.
6. Vitek C, Aduddell M, Brinton M, Hoffman R, Redd S (1999) Increased protections during a measles outbreak of children previously vaccinated with a second dose of measles-mumps-rubella vaccine. Pediatr Infect Dis J 18: 620-623.
7. Aaby P, Knudsen K, Jensen T, Tharup J, Poulsen A, et al. (1990) Measles incidence, vaccine efficacy, and mortality in two urban African areas with high vaccination coverage. J Infect Dis 162: 1043-1048.
8. Cisse B, Aaby P, Simondon F, Samb B, Soumaré M, et al. (1999) Role of schools in the transmission of measles in rural Senegal: implications for measles control in developing countries. Am J Epidemiol 149: 295-301.
9. Malfait P, Jataou I, Jollet M, Margot A, De Benoist A, et al. (1994) Measles epidemic in the urban community of Niamey: transmission patterns, vaccine efficacy and immunization strategies, Niger, 1990 to 1991. Pediatr Infect Dis J 13: 38-45.
10. Kaye S, Miles D, Antoine P, Burny W, Ojuola O, et al. (2008) Virological and immunological correlates of mother to child transmission of cytomegalovirus in The Gambia. J Infect Dis 197.
11. Biggar R, Henle W, Fleisher G, Böcker J, Lennette E, et al. (1978) Primary Epstein-Barr virus infections in African infants. I. Decline of maternal antibodies and time of infection. Int J Cancer 22: 239-243.
12. Martro E, Bulterys M, Stewart J, Spira T, Cannon M, et al. (2004) Comparison of human herpesvirus 8 and Epstein-Barr virus seropositivity among children in areas endemic and non-endemic for Kaposi's sarcoma. J Med Virol 72: 126-131.
13. Sinclair J, Sissons P (2006) Latency and reactivation of human cytomegalovirus. J Gen Virol 87: 1763-1779.
14. Cohen J (2000) Epstein-Barr virus infection. N Engl J Med 343: 481-492.
15. Hochberg D, Souza T, Catalina M, Sullivan J, Luzuriaga K, et al. (2004) Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells. J Virol 78: 5194-5204.
16. de-Thé G, Geser A, Day N, Tukei P, Williams E, et al. (1978) Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature 274: 756-761.
17. Whittle H, Brown J, Marsh K, Greenwood B, Seidelin P, et al. (1984) T-cell control of Epstein-Barr virus-infected B cells is lost during P. falciparum malaria. Nature 312: 449-450.
18. Souza T, Stollar B, Sullivan J, Luzuriaga K, Thorley-Lawson D (2007) Influence of EBV on the Peripheral Blood Memory B Cell Compartment. J Immunol 179: 3153-3160.
19. Söderberg C, Larsson S, Bergstedt-Lindqvist S, Möller E (1993) Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection. J Virol 67: 3166-3175.
20. Gratama JW, Naipal AM, Oosterveer MA, Stijnen T, Kluin-Nelemans HC, et al. (1987) Effects of herpes virus carrier status on peripheral T lymphocyte subsets. Blood 70: 516-523.
21. Looney R, Falsey A, Campbell D, Torres A, Kolassa J, et al. (1999) Role of cytomegalovirus in the T cell changes seen in elderly individuals. Clin Immunol 90: 213-219.
22. Olsson J, Wikby A, Johansson B, Löfgren S, Nilsson B-O, et al. (2000) Agerelated change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev 121: 187-201.
23. Saurwein-Teissl M, Lung T, Marx F, Gschösser C, Asch E, et al. (2002) Lack of antibody production following immunization in old age: association with CD8 + CD282 T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol 168: 5893-5899.
24. Miles D, van der Sande M, Jeffries D, Kaye S, Ismaili J, et al. (2007) Cytomegalovirus Infection in Gambian Infants Leads to Profound CD8 T Cell Differentiation. J Virol 81: 5766-5776.
25. Trzonkowski P, Mysliwska J, Szmit E, Wieckiewicz J, Lukaszuk K, et al. (2003) Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination - an impact of immunosenescence. Vaccine 21: 3826-3836.
26. Miles D, Sanneh M, Holder B, Crozier S, Nyamweya S, et al. (2008) Cytomegalovirus infection induces T-cell differentiation without impairing antigen-specific responses in Gambian infants. Immunology 124: 388-400.
27. Reingold A, Broome C, Hightower A, Ajello G, Bolan G, et al. (1985) Agespecific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine. Lancet 2: 114-118.
28. WHO (2002) Meningococcal vaccines: polysaccharide and polysaccharide conjugate vaccines. Wkly Epidemiol Rec 77: 331-339.
29. WHO (2005) Enhanced surveillance of epidemic meningococcal meningitis in Africa: a three-year experience. Wkly Epidemiol Rec 80: 313-320.
30. Norrby E, Gollmar Y (1972) Appearance and persistence of antibodies against different virus components after regular measles infections. Infect Immun 6: 240-247.
31. Jaye A, Magnusen A, Whittle H (1997) Human leukocyte antigen class I- and class II-restricted cytotoxic T lymphocyte responses to measles antigens in immune adults. J Infect Dis 177: 1282-1289.
32. Schim van der Loeff M, Sarge-Njie R, Ceesay S, Awasana A, Jaye P, et al. (2003) Regional differences in HIV trends in The Gambia: results from sentinel surveillance among pregnant women. AIDS 17: 1841-1846.
33. Duah N, Miles D, Whittle H, Conway D (2010) Acquisition of antibody isotypes against Plasmodium falciparum blood stage antigens in a birth cohort. Parasite Immunol 32: 125-134.
34. Dutta S, Lalitha P, Ware L, Barbosa A, Moch J, et al. (2002) Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli. Infect Immun 70: 3101-3110.
35. Polley S, Conway D, Cavanagh D, McBride J, Lowe B, et al. (2006) High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya. Vaccine 24: 4233-4246.
36. Cavanagh D, Elhassan I, Roper C, Robinson V, Giha H, et al. (1998) A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan. J Immunol 161: 347-359.
37. Gheesling LL, Carlone GM, Pais LB, Holder PF, Maslanka SE, et al. (1994) Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay. J Clin Microbiol 32: 1475-1482.
38. Whittle H, Mann G, Eccles M, O'Neill K, Jupp L, et al. (1988) Effects of dose and strain of vaccine on success of measles vaccination of infants aged 4-5 months. Lancet 331: 963-966.
39. Miller G, Shope T, Lisco H, Stitt D, Lipman M (1972) Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes. Proc Natl Acad Sci USA 69: 383-387.
40. Klein G, Dombos L, Gothoskar B (1972) Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus. Int J Cancer 10: 44-57.
41. Pfaffl MW (2001) A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Res 29: e45.
42. Grivel J-C, Ito Y, Faga G, Santoro F, Shaheen F, et al. (2001) Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6. Nat Med 7: 1232-1235.
43. Grivel J-C, García M, Moss WJ, Margolis LB (2005) Inhibition of HIV-1 replication in human lymphoid tissues ex vivo by measles virus. J Infect Dis 192: 71-78.
44. Clute S, Watkin L, Cornberg M, Naumov Y, Sullivan J, et al. (2005) Crossreactive influenza virus-specific CD8 + T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis. J Clin Invest 115: 3602-3612.
45. Sze D-Y, Toellner K-M, García de Vinuesa C, Taylor D, MacLennan I (2000) Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival. J Exp Med 192: 813-821.
46. Ben-Smith A, Gorak-Stolinska P, Floyd S, Weir R, Lalor M, et al. (2008) Differences between naive and memory T cell phenotype in Malawian and UK adolescents: a role for Cytomegalovirus? BMC Infect Dis 8: 139.
47. Siegrist C-A (2003) Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine. pp 3406-3412.
48. Aaby P, Bukh J, Lisse IM, Smits AJ (1984) Overcrowding and intensive exposure as determinants of measles mortality. Am J Epidemiol 120: 49-63.
49. Xiao L, Owen S, Rudolph D, Lal R, Lal A (1998) Plasmodium falciparum antigeninduced human immunodeficiency virus type 1 replication is mediated through induction of tumor necrosis factor-a. J Infect Dis 177: 437-445.
50. O'Dempsey T, McArdle T, Ceesay S, Secka O, Demba E, et al. (1996) Meningococcal antibody titres in infants of women immunised with meningococcal polysaccharide vaccine during pregnancy. Arch Dis Child Fetal Neonatal Ed 74: F43-46.
51. Blakebrough I, Greenwood B, Whittle H, Bradley A, Gilles H (1982) The epidemiology of infections due to Neisseria meningitidis and Neisseria lactamica in a northern Nigerian community. J Infect Dis 146: 626-637.
52. Aaby P, Samb B, Simondon F, Seck A, Knudsen K, et al. (1995) Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries. BMJ 311: 481-485.
53. Aaby P, Garly ML, Nielsen J, Ravn H, Martins C, et al. (2007) Increased femalemale mortality ratio associated with inactivated polio and diphtheria-tetanuspertussis vaccines: Observations from vaccination trials in Guinea-Bissau. Pediatr Infect Dis J 26: 247-252.